News
By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended ...
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
India supplies 70% of World Health Organization (WHO) vaccines and 14% of the United States generic drug imports, reaffirming its global leadership in affordable, quality healthcare and pharmaceutical ...
Senators Bernie Sanders and Angus King have introduced the End Prescription Drug Ads Now Act, a bill that would ban all ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The U.S. Food and Drug Administration has rolled out a new AI assistant, Elsa, that it says will increase efficiency at its ...
US FDA Extends Review of KalVista's Swelling Disorder Drug Due to Heavy Workload By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results